Tian Sun

Tian Sun

Auto-generated profile, based on publicly available information

Tian Sun

Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2022 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
MSMichel Pompeu B.O. Sá
Michel Pompeu B.O. Sá
XJXander Jacquemyn
Xander Jacquemyn
TSTian Sun
Tian Sun
Jef Van den EyndeJef Van den Eynde
Jef Van den Eynde
Panagiotis TasoudisPanagiotis Tasoudis
Panagiotis Tasoudis
BRBasel Ramlawi
Basel Ramlawi
Permanent pacemaker implantation (PPI) after transcatheter aortic valve replacement (TAVR) is relatively frequent, and its impact on outcomes during follow-up remains a matter of discussion. Previous meta-analyses have yielded conflicting results. To compare late outcomes in patients after TAVR with and without PPI, PubMed/MEDLINE, Embase, and Google Scholar were searched for studies that reported rates of mortality/survival, rehospitalization for heart failure (HF), stroke, and/or endocarditis accompanied by at least 1 Kaplan-Meier curve for any of these outcomes. We adopted a 2-stage approach to reconstruct individual patient data on the basis of the published Kaplan-Meier graphs. Twenty-eight studies with Kaplan-Meier curves met our eligibility criteria and included a total of 50,282 patients (7232 who underwent PPI and 42,959 who did not undergo PPI). Patients who underwent PPI after TAVR had a significantly higher risk of mortality (hazard ratio [HR], 1.21; 95% CI, 1.14-1.28; P < .001) and HF-related rehospitalization (HR, 1.30; 95% CI, 1.17-1.45; P < .001) over time. We did not observe statistically significant differences in the incidence of stroke (HR, 1.07; 95% CI, 0.55-2.08; P = .849) and endocarditis (HR, 0.98; 95% CI, 0.61-1.57; P = .925) during follow-up. Patients who undergo PPI after TAVR experience higher risk of mortality and HF-related rehospitalization over time. These findings provide support for the implementation of procedural strategies to prevent heart conduction disorder and, thus, avoid PPI at the time of TAVR.

12 November 2025 in Annals of Thoracic Surgery Short Reports
Verified
Journal Article
Open access
CCCristina Cusmai
Cristina Cusmai
SGShubham Gulati
Shubham Gulati
DLDaniel Laskey
Daniel Laskey
TSTian Sun
Tian Sun
HBHelena Bugacov
Helena Bugacov
SSScott Scheinin
Scott Scheinin
Lung transplant provides a durable long-term option for group III pulmonary hypertension patients. Historically, bilateral lung transplant is the preferred option due to superior long-term survival. This benefit manifests itself after 2 years posttransplantation. Recipient medical urgency and organ availability may blunt the benefits of bilateral lung transplant over single lung transplant, necessitating alternative transplant strategies. We report a patient with group III pulmonary hypertension with clinical deterioration while awaiting double lungs who underwent salvage single lung transplant. The patient demonstrated excellent graft function with pulmonary hypertension resolution, highlighting the beneficial potential role of single lung transplant in this patient group.